Asarina Pharma ApS: Financial statements 2019
CVR: 38495712
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Asarina Pharma ApS (CVR 38495712) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,446,125 and a net result of DKK -52,387,015 compared with DKK -31,279,340,000 the year before. Equity in the 2019 report amounted to DKK 51,051,938. The solvency ratio was 80.1%. The company had 3 employees in the financial year.
- Gross Profit
- DKK -1,446,125
- Profit/Loss
- DKK -52,387,015
- Equity
- DKK 51,051,938
- Total Assets
- DKK 63,760,382
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1.4 mio. | -52.4 mio. | 51.1 mio. | 3 |
| 2018 | - | -891.9 mio. | -31.3 mia. | 12.1 mia. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Asarina Pharma ApS has published its annual report for 2018. Gross profit came to DKK -891,919,000, and the net result was DKK -31,279,340,000.
About Asarina Pharma ApS
Asarina Pharma ApS was a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2017. The company has been dissolved on 30 June 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Asarina Danmark ApS. The company has 1 employee (2025). In 2024, the company reported a gross profit of DKK -365,453 and a net result of DKK -1,333,232 compared with DKK -42,903,193 the year before. Equity in the 2024 report amounted to DKK -107,343.